(GlaxoSmithKline) – Together with NC BIO, the NC Chamber, and the We Work For Health Initiative, Scott and his colleagues at GSK brought together about 100 business leaders, policy makers and non-profit leaders to celebrate the industry and discuss the sector’s economic impact and opportunities for growth.
Meet our 2021 Employee Champions. We recognize individuals who strive to advance science and support innovation so that patients around the world can get the medicines and treatments they need. This year’s recipients have demonstrated commitment and resiliency that goes above and beyond expectations.
Christine Smith
VP & Head of the Pfizer Biotherapeutics and Pharmaceutical Sciences Department/Chesterfield, MO Site Leader | Pfizer Inc
Christine leads Pfizer’s Biotherapeutics Pharmaceutical Sciences (BTx Pharm Sci) with five global sites and is accountable for overseeing and providing strategic direction and operational implementation for aspects of advancing the Pfizer biologics and vaccines clinical portfolio. Earlier this year, she joined Missouri Governor Mike Parson during his daily COVID-19 briefing and highlighted the role the
Bruce Smith
(GlaxoSmithKline) – As an active volunteer and supporter of the American Diabetes Association of Oregon for over a decade, Bruce has been a member of the auction committee and helped lead its fundraising efforts. His dedication has never been about product; it’s not about sales, but about strengthening patient advocacy and improving quality care.
Dr. Gary Starling
AVP, Biology-Discovery Protein Science | Merck
Dr. Starling plays the invaluable role in supporting Merck’s work on political and federal advocacy issues by providing not only content expertise on Merck’s portfolio of products and development pipeline, but also helping ensure that the government affairs team is able to educate congressional staff on issues surrounding the innovation ecosystem and Merck’s commitment to
Peggy Staver
(Pfizer) – Peggy has been traveling to Washington for the past year-and-a-half to push for the enactment of a national tracing program to ensure the integrity of pharmaceutical products throughout the supply chain and has been relied on by numerous members of Congress.
Frank Stone
Director, U.S. Managed Markets Finance | Merck
Frank has played an instrumental role in helping Merck conduct extensive modeling of the economic and market impact of a wide variety of legislative and regulatory proposals. He has a passion for using data to explain the underlying business environment and has done that for Merck since 2006. This work helps Merck and the industry
Adam Taliaferro
Associate Director, State Strategy & Policy | Bristol-Myers Squibb
(Bristol-Myers Squibb) After his workday is over, Adam not only represents his hometown in the New Jersey state legislature, he is also an advocate for patients and the health care industry through his foundation. The Adam Taliaferro Foundation provides emotional, financial and educational support to individuals who suffer catastrophic head or spinal injuries and supports
Denise Tucker
(Merck) – Denise is a leader who drives her company’s policy priorities and, in turn, our industry’s. From Part D to Health Care Reform Implementation, Denise helps partners understand the implications and how our collaborative work will, ultimately, help better patients’ lives.
Rondu Vincent
Executive Director of Global Supplier Diversity & Sustainability | Bristol Myers Squibb
As Executive Director of Global Supplier Diversity & Sustainability at BMS, Rondu is deeply involved with key organizations geared towards supplier diversity and has forged strong partnerships with over 25 international and national advocacy groups for small and diverse businesses. Additionally, he played a huge role in BMS’ COVID-19 response efforts. To support small/diverse suppliers
Troy Webb
VP Pharma Supply Chain & Strategy, Future Ready Transformation | GlaxoSmithKline
Troy Webb serves as VP Pharma Supply Chain & Strategy, Future Ready Transformation. In addition to overseeing the production of the company’s respiratory medications, he is also a great partner to GSK’s government relations team. He is willing to take the time to educate elected officials on the important lifesaving medications being produced by the